{"entity":{"id":"nct07802652","kind":"trial","name":"Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma","aka":[],"tldr":"A phase 2 trial of DT-7012 run by Gustave Roussy, Cancer Campus, Grand Paris, not yet recruiting.","summary":"Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma is a phase 2 interventional study registered as NCT07802652 by Gustave Roussy, Cancer Campus, Grand Paris, with 80 participants planned, started 2027-02-01. Conditions recorded: Undifferentiated Pleomorphic Sarcoma (UPS) and Dedifferentiated Liposarcoma (DDLPS). Interventions recorded: DT-7012 and Doxorubicin.","status":"planned","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07802652","url":"https://clinicaltrials.gov/study/NCT07802652"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["undifferentiated-pleomorphic-sarcoma","sarcoma"],"sections":[],"technologies":[],"targets":[],"drugs":["dt-7012"],"companies":["domain-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07802652","phase":"2","setting":"A Randomized Phase II Study of Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","enrolled":80,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07802652/","neighbours":{"cancer":[{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"},{"id":"undifferentiated-pleomorphic-sarcoma","kind":"cancer","name":"Undifferentiated pleomorphic sarcoma (UPS)","route":"/cancers/undifferentiated-pleomorphic-sarcoma/"}],"drug":[{"id":"dt-7012","kind":"drug","name":"DT-7012","route":"/drugs/dt-7012/"}],"company":[{"id":"domain-therapeutics","kind":"company","name":"Kainova Therapeutics","route":"/companies/domain-therapeutics/"}]}}